JoVE Logo
Faculty Resource Center

Sign In

腫瘍治療領域(TTFields)を用いた癌細胞の最適阻害頻度の決定

14.2K Views

08:14 min

May 4th, 2017

DOI :

10.3791/55820-v

May 4th, 2017

14,245 Views

1Preclinical Research Department, Novocure Ltd., Haifa, Israel, 2Novocure Ltd., Haifa, Israel, 3Novocure GmbH, Lucerne, Switzerland

Transcript

Explore More Videos

123 TTFields inovitro
JoVE Logo

Privacy

Terms of Use

Policies

Research

Education

ABOUT JoVE

Copyright © 2024 MyJoVE Corporation. All rights reserved